The inaugural conference on Scale-Up and Manufacturing of Cell-Based Therapies is scheduled for January 11-13, 2012 and will take place at the Catamaran Hotel in San Diego

This conference will focus on process development, scale-up, and manufacturing of cell-based therapies and will bring academicians, clinicians, industry leaders, and regulators from all over the world together to discuss the most critical scientific and engineering challenges in this field. It is our aim that this conference will play a central role in defining and refining the engineering sciences of cell based therapies, in much the same way that other high caliber ECI conferences, such as Cell Culture Engineering, Vaccine Technology, and Metabolic Engineering, have helped define those fields.

Organizing Committee Members
Dawn Applegate, RegeneMed
John Aunins, Merck
Anthony Davies, Geron
Robert Deans, Athersys
Avinoam Kadouri, Rainbow Biotechnologies
William M. Miller, Northwestern University
James M. Piret, University of British Columbia
Bob Preti, Progenitor Cell Therapy
Jon Rowley, Lonza Cell Therapy Group
Peter Zandstra, University of Toronto

Session Topics

• Process Technology (Co-Chairs: Peter Zandstra, University of Toronto; Dolores Baksh, Organogenesis)
• Process Development – Allogeneic Cell Therapies (Co-Chairs: Thomas Brieva, Celgene; Joaquim Cabral, Technical University of Lisbon)
• Process Development – Autologous Cell Therapies (Co-Chairs: Robert Preti, Progenitor Cell Therapy; Farlan Veraitch, University College London)
• Product Purification, Formulation and Storage (Co-Chairs: Ravinder Bhatia, J&J; Allison Hubel, University of Minnesota)
• Product Characterization (Co-Chairs: Kim Warren, Lonza; Bill Miller, Northwestern University)
• Business Models (Co-Chairs: Robert Deans, Athersys; Chris Mason, University College London)